Urinary Incontinence
📧 Sign up to get email alerts when something new happens for Urinary Incontinence.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: Lessons on Urethral Lidocaine in Urodynamics [Phase 4]
A Phase 4 clinical trial update discusses urethral lidocaine use during urodynamics, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-07-20Clinical Trial Update: Transobturator Verus Single Incision Slings [NA]
Clinical trial update for a transobturator Verus single incision sling in stress urinary incontinence completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Chlorhexidine vs. Iodine for Vaginal Preparation in Urogynecologic Procedures [Phase 3]
Phase 3 trial comparing chlorhexidine versus iodine for vaginal preparation in urogynecologic procedures has been completed with posted resu…
-
FDA approval · 2023-05-24FDA Approved: OXYBUTYNIN CHLORIDE EXTENDED RELEASE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for oxybutynin chloride extended-release by Rising Pharma Holdings, Inc., confirming the product and…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Acute Pudendal Nerve Stimulation On Leak Point Pressure In Women Urodynamic Early Feasibility Study [NA]
Early feasibility study on acute pudendal nerve stimulation for urinary incontinence in women was terminated; results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-31Clinical Trial Update: Dose-response of Physical Exercise on Pelvic Floor Muscle Function in Postmenopausal Women With Urinary Incontinence [NA]
A completed clinical trial evaluating the dose-response of physical exercise on pelvic floor muscle function in postmenopausal women with ur…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Sacral Neuromodulation in Dual Incontinence: Ultrasound and Afferent Nerve Sensation Assessment [NA]
A terminated clinical trial assessing sacral neuromodulation for dual incontinence, including ultrasound and afferent nerve sensation evalua…
-
FDA approval · 2023-02-02FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for oxybutynin chloride from Accord Healthcare, Inc.
-
FDA approval · 2023-01-27FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Advagen Pharma Limited)
FDA approved a supplemental application for oxybutynin chloride from Advagen Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2022-12-28Clinical Trial Update: OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17) [Phase 3]
Phase 3 trial evaluating onabotulinumtoxinA for urinary incontinence due to overactive bladder in pediatric patients aged 12 to 17 was termi…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Improving Urinary Continence and Quality of Life in Prostate Cancer Patients [NA]
Clinical trial investigating urinary continence improvements and quality of life in prostate cancer patients has completed with results post…
-
FDA approval · 2022-10-07FDA Approved: TROSPIUM CHLORIDE — Supplemental Application (Granules Pharmaceuticals Inc.)
The FDA approved a supplemental application for trospium chloride from Granules Pharmaceuticals Inc. under ANDA213185. This confirms approva…
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Inflammation in Women With Urgency Urinary Incontinence Treated With Anticholinergics [Phase 4]
Phase 4 clinical trial update on inflammation in women with urgency urinary incontinence treated with anticholinergics; results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: The Efficacy of Graminex® Flower Pollen Extracts in Healthy Women With Urinary Incontinence [Phase 2]
Phase 2 trial assessing Graminex flower pollen extracts in healthy women with urinary incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Consumer Evaluation of Intermittent Catheter Product Modifications
A completed clinical trial evaluating consumer evaluation of intermittent catheter product modifications for urinary incontinence with resul…
-
CLINICAL_TRIALS withdrawal · 2022-07-20Clinical Trial Update: Testosterone Effects on Pelvic Floor Muscles [Phase 3]
A Phase 3 clinical trial investigating testosterone effects on pelvic floor muscles for urinary incontinence and menopause has been withdraw…
-
FDA approval · 2022-06-15FDA Approved: SOLIFENACIN SUCCINATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic solifenacin succinate under an original ANDA submission, marking the approval of a generic vers…
-
FDA approval · 2022-02-16FDA Approved: TROSPIUM CHLORIDE — Original Application (Zameer Pharmaceuticals LLC)
FDA approved an original application for trospium chloride (generic) from Zameer Pharmaceuticals LLC, granting market authorization. It is i…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: OnabotulinumtoxinA Bladder Injection Study [Phase 4]
Phase 4 trial of onabotulinumtoxinA injected into the bladder for overactive bladder has been terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Autologous Muscle Derived Cells for Underactive Bladder [Phase 1]
Phase 1 trial assessing autologous muscle-derived cells for underactive bladder has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Platelet Rich Plasma in Women With Urinary Incontinence [Phase 2, Phase 3]
Clinical trial update for Platelet Rich Plasma in women with urinary incontinence, currently in Phase 2/Phase 3.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated autologous cell therapy for stress urinary incontinence in men after prostate surgery; results were po…
-
FDA approval · 2021-10-18FDA Approved: OXYBUTYNIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA has approved a supplemental application for Oxybutynin from Zydus Pharmaceuticals USA Inc., indicating an updated approval for the p…
-
CLINICAL_TRIALS trial_result · 2021-09-23Clinical Trial Update: Investigation of the Effect of the Female Urinary Microbiome on Incontinence [Phase 4]
Phase 4 trial investigating the effect of the female urinary microbiome on urinary incontinence outcomes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence [Phase 2]
Phase 2 clinical trial evaluating intravesical Botox (onabotulinumtoxinA) for overactive bladder with urinary incontinence has completed wit…